Xia H, Zhang Y, Zaongo S, Liang J, Gong X, Hu Y
Ann Transl Med. 2021; 9(10):847.
PMID: 34164481
PMC: 8184475.
DOI: 10.21037/atm-21-1297.
El-Shabrawi M, Kamal N, Mogahed E, Elhusseini M, Aljabri M
Arch Med Sci. 2020; 16(6):1360-1369.
PMID: 33224335
PMC: 7667440.
DOI: 10.5114/aoms.2019.83644.
Wong W, Yang N, Li J, Li H, Wan E, Fitzpatrick T
BMC Public Health. 2020; 20(1):1048.
PMID: 32615951
PMC: 7330974.
DOI: 10.1186/s12889-020-09152-z.
Xia H, Lu C, Wang Y, Zaongo S, Hu Y, Wu Y
Front Pharmacol. 2020; 11:710.
PMID: 32508646
PMC: 7248196.
DOI: 10.3389/fphar.2020.00710.
Revill P, Tu T, Netter H, Yuen L, Locarnini S, Littlejohn M
Nat Rev Gastroenterol Hepatol. 2020; 17(10):618-634.
PMID: 32467580
DOI: 10.1038/s41575-020-0296-6.
Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C.
Wei L, Shang J, Ma Y, Xu X, Huang Y, Guan Y
J Clin Transl Hepatol. 2019; 7(3):221-225.
PMID: 31608213
PMC: 6783684.
DOI: 10.14218/JCTH.2019.00018.
Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China.
Xie Q, Xuan J, Tang H, Ye X, Xu P, Lee I
World J Hepatol. 2019; 11(5):421-441.
PMID: 31183003
PMC: 6547290.
DOI: 10.4254/wjh.v11.i5.421.
Telementoring of primary care providers delivering hepatitis C treatment in New York City: Results from Project INSPIRE.
Teixeira P, Bresnahan M, Laraque F, Litwin A, Shukla S, Schwartz J
Learn Health Syst. 2019; 2(3).
PMID: 31106275
PMC: 6508766.
DOI: 10.1002/lrh2.10056.
Hepatitis C screening in hospitals: find the missing patients.
Liu L, Xu H, Hu Y, Shang J, Jiang J, Yu L
Virol J. 2019; 16(1):47.
PMID: 30992019
PMC: 6469068.
DOI: 10.1186/s12985-019-1157-1.
A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis C virus infection in the era of direct-acting antivirals?.
Yang R, Liu Y, Zhao C, Ding Y, Chen Y, Wang Y
PLoS One. 2019; 14(2):e0211795.
PMID: 30753207
PMC: 6372169.
DOI: 10.1371/journal.pone.0211795.
WHO guidelines on testing for hepatitis B and C - meeting targets for testing.
Hellard M, Chou R, Easterbrook P
BMC Infect Dis. 2017; 17(Suppl 1):703.
PMID: 29143613
PMC: 5688468.
DOI: 10.1186/s12879-017-2765-2.
Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?.
Bognar C, Bychkovsky B, de Lima Lopes Jr G
J Glob Oncol. 2017; 2(5):292-301.
PMID: 28717715
PMC: 5493268.
DOI: 10.1200/JGO.2016.005363.
Effect of season and sunlight on viral kinetics during hepatitis C virus therapy.
Hernandez-Alvarez N, Pascasio Acevedo J, Quintero E, Fernandez Vazquez I, Garcia-Eliz M, De La Revilla Negro J
BMJ Open Gastroenterol. 2017; 4(1):e000115.
PMID: 28321328
PMC: 5353279.
DOI: 10.1136/bmjgast-2016-000115.
Anti-hepatitis C virus seroprevalence in the working age population in Poland, 2004 to 2014.
Walewska-Zielecka B, Religioni U, Juszczyk G, Wawrzyniak Z, Czerw A, Soszynski P
Euro Surveill. 2017; 22(2).
PMID: 28106526
PMC: 5404489.
DOI: 10.2807/1560-7917.ES.2017.22.2.30441.
Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development.
Cuypers L, Li G, Neumann-Haefelin C, Piampongsant S, Libin P, Van Laethem K
Virus Evol. 2016; 2(2):vew024.
PMID: 27774307
PMC: 5072459.
DOI: 10.1093/ve/vew024.
Diagnosis of hepatitis C virus infection in pregnant women in the healthcare system in Poland: Is it worth the effort?.
Walewska-Zielecka B, Religioni U, Juszczyk G, Czerw A, Wawrzyniak Z, Soszynski P
Medicine (Baltimore). 2016; 95(30):e4331.
PMID: 27472714
PMC: 5265851.
DOI: 10.1097/MD.0000000000004331.
Hepatitis C Virus Genotype Analyses in Chronic Hepatitis C Patients and Individuals With Spontaneous Virus Clearance Using a Newly Developed Serotyping Assay.
Yang R, Yang X, Xiu B, Rao H, Fei R, Guan W
J Clin Lab Anal. 2016; 31(1).
PMID: 27292225
PMC: 6817036.
DOI: 10.1002/jcla.22014.
Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective.
Bhatti A, Dar F, Waheed A, Shafique K, Sultan F, Shah N
Gastroenterol Res Pract. 2016; 2016:5942306.
PMID: 26955390
PMC: 4756136.
DOI: 10.1155/2016/5942306.
Hepatitis C virus: A time for decisions. Who should be treated and when?.
Attar B, Van Thiel D
World J Gastrointest Pharmacol Ther. 2016; 7(1):33-40.
PMID: 26855810
PMC: 4734952.
DOI: 10.4292/wjgpt.v7.i1.33.
Individualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China.
Nan Y, Zhang Y, Zheng H, An C, Li Y, Zhang Y
Int J Clin Exp Med. 2015; 8(9):14871-84.
PMID: 26628969
PMC: 4658858.
